Spots Global Cancer Trial Database for unresectable malignant neoplasm
Every month we try and update this database with for unresectable malignant neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain | NCT01846429 | Tumor Cancer Pain Malignant Solid... Unresectable Ma... Hematologic Mal... Multiple Myelom... Lymphoma Neoplasm Metast... | Sodium Bicarbon... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction | NCT01366144 | Breast Carcinom... Carcinoma of Un... Endometrial Car... Esophageal Carc... Liver Failure Lung Carcinoma Malignant Head ... Malignant Testi... Melanoma Metastatic Mali... Ovarian Carcino... Renal Failure Unresectable Ma... Urothelial Carc... | Carboplatin Laboratory Biom... Paclitaxel Pharmacological... Veliparib | 18 Years - | National Cancer Institute (NCI) | |
| Chemoradiotherapy in Unresectable Esophageal Cancer | NCT04278287 | Esophageal Canc... Chemoradiothera... Albumin-bound P... Unresectable Ma... | Radiotherapy Albumin-Bound P... Cisplatin | 18 Years - 75 Years | ChineseAMS | |
| Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery | NCT02583269 | Advanced Malign... Metastatic Mali... Unresectable Ma... | Laboratory Biom... Muscadine Grape... Quality-of-Life... | 18 Years - | Wake Forest University Health Sciences | |
| A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors | NCT03238027 | Solid Tumor Metastatic Tumo... Locally Advance... Unresectable Ma... | Axatilimab Durvalumab | 18 Years - | Syndax Pharmaceuticals | |
| Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer | NCT03777813 | Esophagus Cance... Unresectable Ma... | Durvalumab IMRT 50 Gy + FO... | 18 Years - | UNICANCER | |
| Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors | NCT03108131 | Skin Squamous C... Appendix Adenoc... Rare Lesion Locally Advance... Locally Advance... Metastatic Mali... Metastatic Skin... Metastatic Smal... Rare Neoplastic... Refractory Mali... Stage IV Small ... Unresectable Ma... | Atezolizumab Cobimetinib | 18 Years - | M.D. Anderson Cancer Center | |
| Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE) | NCT05308966 | Malignant Pleur... Unresectable Ma... | Data collection | 18 Years - | Groupe Francais De Pneumo-Cancerologie | |
| ImmunoPET With an Anti-CD8 Imaging Agent | NCT04029181 | Metastatic Canc... Unresectable Ma... | Anti-CD8 PET im... | 18 Years - | University Medical Center Groningen | |
| Chemoradiotherapy in Unresectable Esophageal Cancer | NCT04278287 | Esophageal Canc... Chemoradiothera... Albumin-bound P... Unresectable Ma... | Radiotherapy Albumin-Bound P... Cisplatin | 18 Years - 75 Years | ChineseAMS | |
| Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain | NCT01846429 | Tumor Cancer Pain Malignant Solid... Unresectable Ma... Hematologic Mal... Multiple Myelom... Lymphoma Neoplasm Metast... | Sodium Bicarbon... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| ImmunoPET With an Anti-CD8 Imaging Agent | NCT04029181 | Metastatic Canc... Unresectable Ma... | Anti-CD8 PET im... | 18 Years - | University Medical Center Groningen | |
| Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery | NCT02583269 | Advanced Malign... Metastatic Mali... Unresectable Ma... | Laboratory Biom... Muscadine Grape... Quality-of-Life... | 18 Years - | Wake Forest University Health Sciences | |
| Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction | NCT01366144 | Breast Carcinom... Carcinoma of Un... Endometrial Car... Esophageal Carc... Liver Failure Lung Carcinoma Malignant Head ... Malignant Testi... Melanoma Metastatic Mali... Ovarian Carcino... Renal Failure Unresectable Ma... Urothelial Carc... | Carboplatin Laboratory Biom... Paclitaxel Pharmacological... Veliparib | 18 Years - | National Cancer Institute (NCI) | |
| Colorectal Metastasis and Liver Transplantation With Organs From Deceased Donors | NCT04870879 | Colorectal Live... Colorectal Aden... Unresectable Ma... | Liver Transplan... Chemotherapy | 18 Years - 70 Years | Azienda Ospedaliera di Padova | |
| Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer | NCT03240861 | HLA-A*0201 Posi... Locally Advance... NY-ESO-1 Positi... Unresectable Ma... Sarcoma | 18F-FHBG Aldesleukin Busulfan Cellular Therap... Computed Tomogr... Filgrastim Fludarabine Leukapheresis Plerixafor Positron Emissi... | 16 Years - | Jonsson Comprehensive Cancer Center | |
| Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery | NCT02566421 | Metastatic Neop... Recurrent Neopl... Recurrent Non-S... Stage IIIA Non-... Stage IIIB Non-... Stage IV Non-Sm... Unresectable Ma... | Laboratory Biom... Quality-of-Life... Targeted Therap... | 18 Years - | Wake Forest University Health Sciences | |
| Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery | NCT02583269 | Advanced Malign... Metastatic Mali... Unresectable Ma... | Laboratory Biom... Muscadine Grape... Quality-of-Life... | 18 Years - | Wake Forest University Health Sciences | |
| Bevacizumab in Combination With Chemotherapy in Patients With Advanced or Recurrent Non-squamous NSCLC | NCT01963351 | Non-small Cell ... Unresectable Ma... | 18 Years - | University of Athens |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
